Latest Commercial Growth News

Page 3 of 9
Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.
Claire Turing
Claire Turing
23 Mar 2026
InteliCare Holdings has appointed seasoned healthcare executive Angus Cameron as CEO to lead its transition from pilot projects to full-scale commercial deployment following a major aged care contract.
Victor Sage
Victor Sage
17 Mar 2026
TZ Limited has completed a A$1.5 million capital raise at a premium, appointed David Sampaklis as Group CEO with significant shareholding, and repaid A$1 million of debt, positioning itself for growth in data centre security.
Sophie Babbage
Sophie Babbage
12 Mar 2026
Straker Ltd announces a pivotal leadership shift with the appointment of David Sowerby and Indiver Nagpal as Co-CEOs, marking a new era focused on commercial expansion and AI innovation. Founder Grant Straker transitions to a strategic board role to steer the company’s AI future.
Sophie Babbage
Sophie Babbage
4 Mar 2026
Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.
Eva Park
Eva Park
3 Mar 2026
Brisbane Broncos Limited has reported a robust 2025 financial year, with profit before tax soaring 35% to $11.34 million, buoyed by premiership wins in both the NRL and NRLW competitions. The club also declared a special dividend, reflecting its strong commercial and community momentum.
Victor Sage
Victor Sage
27 Feb 2026
BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Immuron Limited reported a narrower half-year loss alongside record sales growth and FDA approval for its IMM-529 drug candidate, signalling promising clinical and commercial momentum.
Ada Torres
Ada Torres
25 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
Winton Land Limited reports a sharp 60% revenue decline in its interim results for H1 FY26 but narrows its net loss and progresses key development projects amid a cautious economic backdrop.
Eva Park
Eva Park
20 Feb 2026
Eden Innovations has taken a major step in strengthening its balance sheet by converting a $2.2 million loan into equity, positioning the company debt free and ready to accelerate growth.
Victor Sage
Victor Sage
16 Feb 2026
RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.
Ada Torres
Ada Torres
10 Feb 2026